252 related articles for article (PubMed ID: 33386338)
1. Enteral Vitamin A for Reducing Severity of Bronchopulmonary Dysplasia: A Randomized Trial.
Rakshasbhuvankar AA; Simmer K; Patole SK; Stoecklin B; Nathan EA; Clarke MW; Pillow JJ
Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33386338
[TBL] [Abstract][Full Text] [Related]
2. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
[TBL] [Abstract][Full Text] [Related]
3. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S; Bay J; Franz AR; Ehrhardt H; Klein L; Petzinger J; Binder C; Kirschenhofer S; Stein A; Hüning B; Heep A; Cloppenburg E; Muyimbwa J; Ott T; Sandkötter J; Teig N; Wiegand S; Schroth M; Kick A; Wurm D; Gebauer C; Linnemann K; Kittel J; Wieg C; Kiechl-Kohlendorfer U; Schmidt S; Böttger R; Thomas W; Brevis Nunez F; Stockmann A; Kriebel T; Müller A; Klotz D; Morhart P; Nohr D; Biesalski HK; Giannopoulou EZ; Hilt S; Poryo M; Wagenpfeil S; Haiden N; Ruckes C; Ehrlich A; Gortner L;
Lancet Respir Med; 2024 Jul; 12(7):544-555. PubMed ID: 38643780
[TBL] [Abstract][Full Text] [Related]
4. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
Meyer S; Gortner L;
Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
[TBL] [Abstract][Full Text] [Related]
5. Effect of Enteral Vitamin A on Fecal Calprotectin in Extremely Preterm Infants: A Nested Prospective Observational Study.
Rakshasbhuvankar AA; Pillow JJ; Patole SK; Nathan EA; Simmer K
Neonatology; 2021; 118(6):720-726. PubMed ID: 34518481
[TBL] [Abstract][Full Text] [Related]
6. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of enteral vitamin D supplementation (ViDES) in infants <28 weeks gestational age or <1000 g birth weight: study protocol.
Romero-Lopez M; Tyson JE; Naik M; Pedroza C; Holzapfel LF; Avritscher E; Mosquera R; Khan A; Rysavy M
Trials; 2024 Jun; 25(1):423. PubMed ID: 38943179
[TBL] [Abstract][Full Text] [Related]
8. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Early Vitamin D Supplementation in Critically Ill Extremely Preterm Infants: An Ancillary Study of a Randomized Trial.
Aristizabal N; Holder MP; Durham L; Ashraf AP; Taylor S; Salas AA
J Acad Nutr Diet; 2023 Jan; 123(1):87-94. PubMed ID: 35728797
[TBL] [Abstract][Full Text] [Related]
10. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial.
Abounahia FF; Abu-Jarir R; Abounahia MF; Al-Badriyeh D; Abushanab D; Abu-Ghalwa M; Mansour A; Kurdi B; Al-Rifai H
Clin Drug Investig; 2019 Nov; 39(11):1093-1107. PubMed ID: 31414269
[TBL] [Abstract][Full Text] [Related]
12. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity.
Mactier H; McCulloch DL; Hamilton R; Galloway P; Bradnam MS; Young D; Lavy T; Farrell L; Weaver LT
J Pediatr; 2012 Jun; 160(6):954-9.e1. PubMed ID: 22284923
[TBL] [Abstract][Full Text] [Related]
13. Nebulized pentoxifylline for reducing the duration of oxygen supplementation in extremely preterm neonates.
Schulzke SM; Deshmukh M; Nathan EA; Doherty DA; Patole SK
J Pediatr; 2015 May; 166(5):1158-1162.e2. PubMed ID: 25748566
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of 3 Vitamin D Dosing Regimens in Extremely Preterm Infants: A Randomized Controlled Trial.
Fort P; Salas AA; Nicola T; Craig CM; Carlo WA; Ambalavanan N
J Pediatr; 2016 Jul; 174():132-138.e1. PubMed ID: 27079965
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants.
Werkman SH; Peeples JM; Cooke RJ; Tolley EA; Carlson SE
Am J Clin Nutr; 1994 Mar; 59(3):586-92. PubMed ID: 8116534
[TBL] [Abstract][Full Text] [Related]
16. Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial.
Rysavy MA; Li L; Tyson JE; Jensen EA; Das A; Ambalavanan N; Laughon MM; Greenberg RG; Patel RM; Pedroza C; Bell EF;
J Pediatr; 2021 Sep; 236():78-85.e5. PubMed ID: 34004189
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very-low-birth-weight premature Thai infants: a randomized trial.
Kiatchoosakun P; Jirapradittha J; Panthongviriyakul MC; Khampitak T; Yongvanit P; Boonsiri P
J Med Assoc Thai; 2014 Oct; 97 Suppl 10():S82-8. PubMed ID: 25816542
[TBL] [Abstract][Full Text] [Related]
18. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
[TBL] [Abstract][Full Text] [Related]
19. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
20. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.
Gadhia MM; Cutter GR; Abman SH; Kinsella JP
J Pediatr; 2014 Apr; 164(4):744-8. PubMed ID: 24388327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
